Almac Receives Appreciation Award from OAPI
News Aug 02, 2013
In June 2013, Almac has hosted Otsuka America Pharmaceutical Inc.’s (OAPI) Clinical Trial Supply team at Almac’s North American Headquarters in Souderton, PA.
The highlight of the meeting was a presentation of an award to the Almac Clinical Services team by Brent Kelly, OAPI’s Director of Clinical Supply Operations.
Almac provided crucial clinical supply services for OAPI’s Abilify Maintena™ (aripiprazole) clinical trial program, supporting the approval of the once-monthly injectable treatment for schizophrenia earlier in 2013.
This recognizes Almac’s commitment to quality, customer service, and operational excellence.
Commenting on the award Celine Bradley, Almac’s Global VP of Operations said, “I am proud to receive this award from one of our valued customers, and I would like to congratulate OAPI on their successful registration of the Abilify Maintena product. Almac’s core values include our commitment to quality and customer focus, and it is very satisfying to have a client recognize when we have delivered on these. I would like to commend the Almac team for their dedication to successful and timely completion of this project. Awards like this highlight the importance of clinical trial supply in enabling our partners to make a real difference in patients’ lives.”
Immune Response Restored in Patients with Melanoma Thanks to New CompoundNews
A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017.READ MORE
Commonly Prescribed Painkillers: What Can be Done to Reduce Risk of Obesity and Sleep Deprivation?News
Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.READ MORE